Metri Bio
PrivateLast Round
Pre Seed
Dec 2, 2025
Total Funding Raised
$5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Metri Bio is a biotechnology company that develops first-in-class therapeutics for endometrial diseases using a proprietary 3D endometrial modeling platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metri Bio Comparables
Compare Metri Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cyclana Bio | 89% | |
| GynQura Therapeutics | 88% | |
| FimmCyte | 77% | |
Metri Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Dec 2, 2025 |
Metri Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pace Ventures | Pre Seed |
| Pillar VC | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2025
$5M round led by Pillar VC
Metri Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Metri Bio's valuation, stock price, and market status.